D. E. Mahony

1.7k total citations
53 papers, 1.4k citations indexed

About

D. E. Mahony is a scholar working on Molecular Biology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, D. E. Mahony has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Infectious Diseases and 15 papers in Clinical Biochemistry. Recurrent topics in D. E. Mahony's work include Clostridium difficile and Clostridium perfringens research (22 papers), Bacterial Identification and Susceptibility Testing (15 papers) and Hormonal Regulation and Hypertension (12 papers). D. E. Mahony is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (22 papers), Bacterial Identification and Susceptibility Testing (15 papers) and Hormonal Regulation and Hypertension (12 papers). D. E. Mahony collaborates with scholars based in Canada, United States and Czechia. D. E. Mahony's co-authors include Ian Macdonald, Neil Burford, C. N. Williams, Melanie D. Eelman, Michael G. Morash, Ian A. MacDonald, Lillian V. Holdeman, Ginette R. Webb, Gurmit Singh and K. B. Easterbrook and has published in prestigious journals such as American Journal of Clinical Nutrition, Applied and Environmental Microbiology and Analytical Biochemistry.

In The Last Decade

D. E. Mahony

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. E. Mahony Canada 22 502 372 243 190 176 53 1.4k
E. Evdokimova Canada 27 1.3k 2.7× 191 0.5× 74 0.3× 422 2.2× 88 0.5× 73 2.2k
Sa-Ouk Kang South Korea 21 773 1.5× 328 0.9× 215 0.9× 102 0.5× 101 0.6× 46 1.8k
Jieling Zhao United States 6 912 1.8× 184 0.5× 132 0.5× 109 0.6× 88 0.5× 7 1.7k
Mahesh Patel India 27 628 1.3× 242 0.7× 84 0.3× 47 0.2× 43 0.2× 100 2.2k
Dolores González‐Pacanowska Spain 35 1.9k 3.9× 458 1.2× 216 0.9× 292 1.5× 85 0.5× 157 3.4k
Santanu Kar Mahapatra India 25 456 0.9× 126 0.3× 69 0.3× 172 0.9× 40 0.2× 77 1.5k
Tyler L. Grove United States 29 1.7k 3.4× 207 0.6× 308 1.3× 250 1.3× 40 0.2× 55 3.0k
Laurent R. Chiarelli Italy 30 1.5k 3.0× 582 1.6× 79 0.3× 141 0.7× 59 0.3× 93 2.7k
W.Y. Jeng Taiwan 21 1.2k 2.3× 304 0.8× 99 0.4× 146 0.8× 69 0.4× 40 1.7k
François Le Goffic France 20 903 1.8× 108 0.3× 66 0.3× 163 0.9× 17 0.1× 93 1.5k

Countries citing papers authored by D. E. Mahony

Since Specialization
Citations

This map shows the geographic impact of D. E. Mahony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. E. Mahony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. E. Mahony more than expected).

Fields of papers citing papers by D. E. Mahony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. E. Mahony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. E. Mahony. The network helps show where D. E. Mahony may publish in the future.

Co-authorship network of co-authors of D. E. Mahony

This figure shows the co-authorship network connecting the top 25 collaborators of D. E. Mahony. A scholar is included among the top collaborators of D. E. Mahony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. E. Mahony. D. E. Mahony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burford, Neil, Melanie D. Eelman, D. E. Mahony, & Michael G. Morash. (2002). Definitive identification of cysteine and glutathione complexes of bismuth by mass spectrometry: assessing the biochemical fate of bismuth pharmaceutical agents. Chemical Communications. 146–147. 210 indexed citations
2.
Moos, Michael, et al.. (2001). Variant toxin B and a functional toxin A produced byClostridium difficileC34. FEMS Microbiology Letters. 198(2). 171–176. 29 indexed citations
3.
Braun, Veit, et al.. (2000). A chimeric ribozyme in Clostridium difficile combines features of group I introns and insertion elements. Molecular Microbiology. 36(6). 1447–1459. 34 indexed citations
4.
Mahony, D. E., Rafiq Ahmad, & Susan Jackson. (1992). Multiple typing techniques applied to a Clostridium perfringens food poisoning outbreak. Journal of Applied Bacteriology. 72(4). 309–314. 21 indexed citations
5.
Mahony, D. E., et al.. (1988). Transformation of Clostridium perfringens L forms with shuttle plasmid DNA. Applied and Environmental Microbiology. 54(1). 264–267. 15 indexed citations
6.
Mahony, D. E., et al.. (1987). Plasmid analysis as a means of strain differentiation in Clostridium perfringens. Journal of Clinical Microbiology. 25(7). 1333–1335. 22 indexed citations
7.
Mahony, D. E., et al.. (1986). Rapid extraction of plasmids from Clostridium perfringens. Applied and Environmental Microbiology. 51(3). 521–523. 22 indexed citations
8.
Verpoorte, Jacob A., et al.. (1982). Characterization of bacteriocin 28 produced by Clostridium perfringens. Canadian Journal of Microbiology. 28(7). 860–873. 8 indexed citations
9.
Macdonald, Ian, Ginette R. Webb, & D. E. Mahony. (1978). Fecal hydroxysteroid dehydrogenase activities in vegetarian Seventh-Day Adventists, control subjects, and bowel cancer patients. American Journal of Clinical Nutrition. 31(10). S233–S238. 59 indexed citations
10.
Mahony, D. E., et al.. (1978). Synthesis and Quantitative Structure-Activity Relationships of Antibacterial 1-(Substituted Benzhydryl)-4-(5-nitro-2-furfurylideneamino)piperazines. Journal of Pharmaceutical Sciences. 67(7). 900–905. 7 indexed citations
11.
Macdonald, Ian, D. E. Mahony, C. N. Williams, & Kenneth F. Watson. (1978). 12alpha- and 7alpha-hydroxysteroid dehydrogenase activities from Fusobacterium spp.. PubMed. 31(1-2). 49–57. 1 indexed citations
12.
Mahony, D. E., et al.. (1978). Synthesis and quantitative structure-activity relationships of some antibacterial 3-formylrifamycin SV N-(4-substituted phenyl)piperazinoacethydrazones. Journal of Medicinal Chemistry. 21(12). 1301–1307. 24 indexed citations
13.
Mahony, D. E., et al.. (1978). Bacteriocin typing of Clostridium perfringens in human feces. Journal of Clinical Microbiology. 7(3). 307–309. 9 indexed citations
14.
Mahony, D. E.. (1977). Stable L-Forms of Clostridium perfringens : Growth, Toxin Production, and Pathogenicity. Infection and Immunity. 15(1). 19–25. 6 indexed citations
15.
Macdonald, Ian, et al.. (1976). 3α-, 7α- And 12α-hydroxysteroid dehydrogenase activities from Clostridium perfringens. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 450(2). 142–153. 65 indexed citations
16.
MacDonald, Ian A., C. N. Williams, & D. E. Mahony. (1976). Behavior of 3α- and 7α-hydroxysteroid dehydrogenases on chenodeoxycholate substituted sepharose. Steroids. 28(1). 25–30. 6 indexed citations
17.
Macdonald, Ian, C. N. Williams, & D. E. Mahony. (1975). Lyophilized 7 α-hydroxysteroid dehydrogenase: a stable enzyme preparation for routine bile acid analysis. Journal of Lipid Research. 16(3). 244–246. 9 indexed citations
18.
MacDonald, Ian A., et al.. (1975). Convenient Non-Chromatographic Assays for the Microbial Deconjugation and 7α-OH Bioconversion of Taurocholate. Applied Microbiology. 30(4). 530–535. 10 indexed citations
19.
Mahony, D. E.. (1974). Bacteriocin Susceptibility of Clostridium perfringens : a Provisional Typing Schema. Applied Microbiology. 28(2). 172–176. 29 indexed citations
20.
Mahony, D. E., et al.. (1971). Synthesis and In Vitro Antimicrobial Evaluation of Hydrazones of 1-Phenyl-, 1-Benzyl-, and 1-Benzhydryl-4-aminopiperazines. Journal of Pharmaceutical Sciences. 60(3). 386–389. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Evdokimova Breakdown of academic impact, for papers by Sa-Ouk Kang Breakdown of academic impact, for papers by Jieling Zhao Breakdown of academic impact, for papers by Mahesh Patel Breakdown of academic impact, for papers by Dolores González‐Pacanowska Breakdown of academic impact, for papers by Santanu Kar Mahapatra Breakdown of academic impact, for papers by Tyler L. Grove Breakdown of academic impact, for papers by Laurent R. Chiarelli Breakdown of academic impact, for papers by W.Y. Jeng Breakdown of academic impact, for papers by François Le Goffic
Rankless by CCL
2026